This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Aop Orphan Pharmaceuticals Ag. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: **Inventor Martin Rettig: A Pioneer in Pharmaceutical Innovation**
Introduction
Martin Rettig, located in Schwanau-Nonnenweier, Germany, is a notable inventor recognized for his contributions to the field of pharmaceuticals. With a keen focus on innovative processes, Rettig has made significant strides, culminating in his patent that highlights his expertise and dedication to the advancement of medicine.
Latest Patents
Rettig holds a patent for a groundbreaking process titled "Process for the preparation of 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide and intermediates thereof." This invention introduces a novel methodology for the preparation of rac-6-Chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide in a pharmaceutically acceptable polymorphic form. The process involves the conversion of a 3-bromo-2-oxo-cyclohexanecarboxylic acid alkyl ester into the desired compound, reflecting Rettig's innovative approach to pharmaceutical synthesis.
Career Highlights
Currently, Martin Rettig is employed at AOP Orphan Pharmaceuticals AG, where he contributes to the research and development of valuable pharmaceutical products. His position at such a reputable company underscores his expertise in the field and his commitment to improving health outcomes. Rettig's efforts exemplify the role of inventors in driving progress in the pharmaceutical industry.
Collaborations
Throughout his career, Rettig has collaborated with talented professionals, including his coworkers Enrica Diodato and Katia Marcucci. These collaborations not only highlight his ability to work within a team but also demonstrate the synergy that can arise from collective expertise in the pursuit of innovation.
Conclusion
Martin Rettig's innovative spirit and dedication have led to significant advancements in the preparation of pharmaceutical compounds. His patent serves as a testament to his contributions and the potential impact of his work on future medical therapies. As the pharmaceutical field continues to evolve, the contributions of inventors like Rettig will remain crucial in the quest for new treatments and improved healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile